Varta
← Back to stories

From The Economic Times

Center-Right Owned by Bennett, Coleman & Co.

Assessing products to counter side effects of GLP-1, says Bayer's Triana

Assessing products to counter side effects of GLP-1, says Bayer's Triana

RSS excerpt

Bayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian market during this period. Bayer is specifically targeting opportunities in digestive health, nutrition, and multivitamins related to GLP-1 drug side effects…

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →